Thus, the decrease in u-ENaCγ in CKD patients and the increase in u-ENaCγ in healthy controls might be compensatory mechanisms due to an altered absorptive activity in NKCC2, but further studies are necessary to clarify this hypothesis.. The gene discussed is SLC12A1; the disease is chronic kidney disease.